The ADVOR trial reports the first positive findings for patients with acute decompensated heart failure (ADHF), seeing results in the cohort of patients receiving acetazolamide treatment. In this touchCARDIO interview, we speak with Professor Wilfried Mullens (Hasselt University, Hasselt, Belgium) to discuss the aim of the ADVOR trial in patients with ADHF and the implications of the findings for clinical practice.
The abstract entitled ‘ADVOR – Acetazolamide in acute heart failure’ was presented at the European Society of Cardiology (ESC) Congress 2022, 26 – 29 August 2022.
- Could you give us a brief overview of the limitations of current treatments for decompensated heart failure? (0:19)
- What are the aims and design of the ADVOR trial and how well were the primary and secondary outcome measures achieved? (0:53)
- What are the implications of these findings for clinical practice? (2:16)
Disclosures: Wilfried Mullens has nothing to disclose in relation to this video interview.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Danielle Crosby.
Filmed as a highlight of ESC 2022
Access more content on Heart Failure here
Share this Video
Related Videos In Heart Failure
Divaka Perera, ESC 2022: Percutaneous revascularisation in patients with severe ischaemic cardiomyopathy, the REVIVED trial
The REVIVED study aimed to assess whether the addition of stents when treating patients with severe ischaemic cardiomyopathy would be beneficial to patient outcomes. In this touchCARDIO interview, we speak with Professor Divaka Perera (King’s College London, London, UK) to discuss the REVIVED trial, its outcomes and how they will affect the current treatment paradigm. […]
Divaka Perera, ESC 2022: The unmet needs in patients with heart failure due to ischaemic cardiomyopathy
In an ideal scenario, patients with ischaemic cardiomyopathy would receive specific treatment options beyond the general heart failure management currently in place. In this touchCARDIO interview, we speak with Professor Divaka Perera (King’s College London, London, UK) to discuss the unmet needs in this population and give an evaluation of surgical and percutaneous revascularization in […]
Caroline Sindet-Pedersen, ESC 2022: SARS-CoV-2 mRNA vaccines in patients with heart failure
Studies investigating the safety and efficacy of the severe acute respiratory syndrome coronavirus 2 infection (SARS-CoV-2) mRNA vaccines lacked representation of patients with heart failure. In this touchCARDIO interview, we speak with Dr Caroline Sindet-Pedersen (Copenhagen University Hospital Herlev and Gentofte, Hellerup, Denmark) to discuss the study presented at ESC 2022 that aimed to investigate […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!